Regarding glioma subtype the accuracy was higher in IDH-mut glioma potentially explained by the increased cellular heterogeneity observed in IDH-wt GBM, including areas of necrosis and other structural variations. The gene discussed is IDH1; the disease is central nervous system cancer.